Doxycycline Hyclate 100 mg Capsule
| Feature | Details |
|---------|---------|
| Drug class | Tetracycline antibiotic |
| Form | Oral capsule (100 mg of doxycycline hyclate) |
| Typical strengths | 100 mg; some compounding pharmacies may offer 200 mg or lower doses |
| Common brand names | Vibramycin®, Doxycycline® (generic), among others |
---
1. Indications (Common Uses)
| Infection / Condition | Typical regimens (adult) | Notes |
|------------------------|--------------------------|-------|
| Acute bacterial infections (e.g., sinusitis, bronchitis) | 100 mg PO BID for 7–14 days | Short courses often suffice |
| Community‑acquired pneumonia | 100 mg PO BID for 7–14 days | Alternative when β‑lactams contraindicated |
| Skin & soft‑tissue infections | 100 mg PO BID for 7–14 days | Works for MRSA‑susceptible strains |
| Acne vulgaris | 50 mg PO BID or 100 mg PO daily for 6–12 months | Often combined with topical retinoids |
| Chlamydia trachomatis (urethritis, cervicitis) | 100 mg PO BID for 7 days (or single 200 mg dose) | 7‑day course widely used |
| Lyme disease (early localized) | 100 mg PO BID for 14–21 days | 21 days preferred if early disseminated |
| Malaria prophylaxis | 100 mg PO daily on days 1‑4 of travel | Usually in combination with other agents |
| Rickettsial & tick‑borne infections | 100 mg PO BID for 5–7 days | Quick onset helps prevent complications |
Always verify the specific regimen with a clinician.
Dosing may differ for children, renal/hepatic impairment, or when used with other drugs.
---
2. Mechanism of Action
Doxycycline inhibits bacterial protein synthesis by binding reversibly to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA. This stops bacterial growth (bacteriostatic) and, at higher concentrations, can be bactericidal.
---
3. Pharmacokinetics
| Parameter | Typical value (adult) |
|-----------|-----------------------|
| Bioavailability | ~80 % (rapid oral absorption) |
| Peak plasma | 1–2 h after dosing |
| Half‑life | 18–22 h (allows BID dosing) |
| Distribution | Widely distributed; high penetration into tissues, bone, and inflamed sites |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Primarily renal (≈ 50 % unchanged); ~ 50 % fecal |
| Caution | Dose adjustment in severe renal or hepatic impairment may be required |
---
4. Contraindications & Precautions
| Category | Key points |
|----------|------------|
| Contraindicated | • Severe renal or hepatic impairment (unless dose adjusted)
• Pregnancy (Category X; can cause dental staining in fetus)
• Children <8 yrs (risk of teeth discoloration, growth inhibition) |
| Precautions | • Antacids, sucralfate, zinc, iron, or calcium products can reduce absorption—administer 2 h before or after.
• Avoid high‑dose vitamin D supplements (risk of hypercalcemia).
• Use with caution in patients on warfarin (may increase INR).
• Monitor for photosensitivity; advise sun protection. |
| Warnings | • Rare but serious hypersensitivity (e.g., Stevens–Johnson syndrome).
• Potential for esophageal injury—take with a full glass of water and sit upright for ≥ 30 min. |
---
5. Common Adverse Effects
| System | Typical incidence |
|--------|-------------------|
| Gastro‑intestinal | Nausea (≈ 20 %), vomiting (≈ 10 %), dyspepsia, diarrhea |
| Dermatologic | Photosensitivity (≈ 10 – 20 %), rash |
| Neurologic | Headache, dizziness |
| Hepatic | Rare transaminase elevations |
| Ophthalmic | Conjunctivitis, blurred vision (rare) |
Management tips
• Take with food if GI upset occurs (may slightly reduce absorption).
• Use broad‑spectrum sunscreens, hats, and avoid prolonged sun exposure.
---
6. Drug Interactions
| Drug class | Interaction |
|------------|-------------|
| Calcium, iron, zinc, magnesium | ↓ Absorption → take 2 h apart |
| Antacids (aluminum, magnesium, calcium) | ↓ Absorption |
| Sucralfate | ↓ Absorption |
| Warfarin | ↑ INR (monitor coagulation) |
| Aluminum hydroxide | ↓ Absorption |
| Cimetidine | ↓ Clearance → ↑ plasma levels |
| Proton‑pump inhibitors (PPIs) | ↓ Absorption |
| CYP3A4 inhibitors (e.g., ketoconazole) | ↑ levels (rare) |
| CYP3A4 inducers (e.g., rifampin) | ↓ levels (reduced efficacy) |
Always review a patient’s full medication list and counsel about timing.
---
7. Patient Counseling Points
1. Take as prescribed – complete the full course even if symptoms improve early.
2. Avoid lying down after dosing – wait at least 30 min upright.
3. Take with a full glass of water – helps prevent esophageal irritation.
4. Avoid dairy products or calcium‑rich foods near dosing time.
5. Sun protection – use broad‑spectrum SPF, wear hats, and avoid peak sun.
6. Report any severe rash, fever, or swelling – could signal an allergic reaction.
7. Do not share the medication – it is tailored to your infection.
---
8. Storage & Handling
- Store at room temperature (15–25 °C).
- Keep in the original container, tightly closed, away from light.
- Keep out of reach of children.
- Do not freeze; do not use if the capsule is damaged or discolored.
---
Quick Reference Sheet (for Clinicians)
| Item | Detail |
|------|--------|
| Dose | 100 mg PO BID (or as per indication) |
| Duration | 7–14 days (or longer for acne) |
| Special | Avoid in pregnancy/children <8 yrs; monitor renal function; adjust dosing if severe CKD/HD |
| Key interactions | Antacids, PPIs, calcium/iron/zinc, warfarin |
---
Bottom Line
Doxycycline hyclate 100 mg capsules are a versatile, well‑studied antibiotic effective against a wide range of bacterial pathogens. Their safety profile is generally favorable, but clinicians must consider patient age, pregnancy status, renal/hepatic function, and concurrent medications. Encourage patients to adhere strictly to dosing instructions, remain vigilant for photosensitivity, and seek medical attention for any unusual or severe adverse reactions.
If you have specific concerns (e.g., how it interacts with a medication you’re taking or whether it’s appropriate for a particular infection), consult your prescribing provider or pharmacist.